Boston Partners trimmed its holdings in Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report) by 5.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 294,434 shares of the company’s stock after selling 17,042 shares during the period. Boston Partners owned about 1.55% of Nature’s Sunshine Products worth $4,019,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Allspring Global Investments Holdings LLC bought a new stake in Nature’s Sunshine Products in the second quarter valued at about $104,000. Los Angeles Capital Management LLC bought a new stake in shares of Nature’s Sunshine Products in the 2nd quarter valued at approximately $320,000. Janney Montgomery Scott LLC raised its position in shares of Nature’s Sunshine Products by 9.5% during the 2nd quarter. Janney Montgomery Scott LLC now owns 21,212 shares of the company’s stock valued at $290,000 after acquiring an additional 1,846 shares in the last quarter. Dynamic Advisor Solutions LLC bought a new position in Nature’s Sunshine Products during the second quarter worth $249,000. Finally, BNP Paribas Arbitrage SNC boosted its holdings in Nature’s Sunshine Products by 63.4% in the third quarter. BNP Paribas Arbitrage SNC now owns 10,791 shares of the company’s stock worth $89,000 after purchasing an additional 4,185 shares during the period. 76.08% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Nature’s Sunshine Products
In related news, EVP Daniel C. Norman sold 12,036 shares of Nature’s Sunshine Products stock in a transaction on Monday, August 28th. The shares were sold at an average price of $16.40, for a total value of $197,390.40. Following the completion of the sale, the executive vice president now owns 69,765 shares of the company’s stock, valued at approximately $1,144,146. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 4.70% of the company’s stock.
Nature’s Sunshine Products Trading Down 1.4 %
Wall Street Analyst Weigh In
A number of analysts have weighed in on the stock. StockNews.com started coverage on shares of Nature’s Sunshine Products in a report on Thursday, October 5th. They set a “strong-buy” rating on the stock. DA Davidson raised their target price on shares of Nature’s Sunshine Products from $19.50 to $21.50 and gave the stock a “buy” rating in a report on Thursday, November 9th. Finally, TheStreet raised Nature’s Sunshine Products from a “c” rating to a “b-” rating in a report on Thursday, August 17th.
Nature’s Sunshine Products Company Profile
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
- Five stocks we like better than Nature’s Sunshine Products
- ETF Screener: Uses and Step-by-Step Guide
- Safeguard your portfolio with these three bargain stocks
- What is the Hang Seng index?
- Membership clubs gain leverage for the consumer rebound
- How to Invest in Fertilizer
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.